{
  "retracted": false,
  "timestamp": 1562716800000,
  "updates": [
    {
      "timestamp": 1564994436590,
      "identifier": {
        "doi": "10.1007/s00280-019-03890-7"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-019-03850-1"
  },
  "journal": "Cancer Chemotherapy and Pharmacology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2‑positive metastatic breast cancer"
}
